CK Life Sciences Int'l., (Holdings) Inc.

SEHK:775 주식 보고서

시가총액: HK$3.1b

이 페이지의 번역은 실험적이며 개발 중입니다. 여러분의 환영합니다!

CK Life Sciences Int'l. (Holdings) 관리

관리 기준 확인 3/4

CK Life Sciences Int'l. (Holdings)'s CEO는 Alan Abel Yu, Sep2020 에 임명되었습니다 의 임기는 3.75 년입니다. 총 연간 보상은 HK$ 14.79M, 74.1% 로 구성됩니다. 74.1% 급여 및 25.9% 보너스(회사 주식 및 옵션 포함). 는 HK$ 776.23K 가치에 해당하는 회사 주식의 0.023% 직접 소유합니다. 776.23K. 경영진과 이사회의 평균 재임 기간은 각각 13.8 년과 9.3 년입니다.

주요 정보

Alan Abel Yu

최고 경영자

HK$14.8m

총 보상

CEO 급여 비율74.1%
CEO 임기3.8yrs
CEO 소유권0.02%
경영진 평균 재임 기간13.9yrs
이사회 평균 재임 기간9.3yrs

최근 관리 업데이트

Recent updates

There's No Escaping CK Life Sciences Int'l., (Holdings) Inc.'s (HKG:775) Muted Revenues Despite A 32% Share Price Rise

May 03
There's No Escaping CK Life Sciences Int'l., (Holdings) Inc.'s (HKG:775) Muted Revenues Despite A 32% Share Price Rise

CK Life Sciences Int'l. (Holdings)'s (HKG:775) Anemic Earnings Might Be Worse Than You Think

Apr 25
CK Life Sciences Int'l. (Holdings)'s (HKG:775) Anemic Earnings Might Be Worse Than You Think

CK Life Sciences Int'l. (Holdings) (HKG:775) Use Of Debt Could Be Considered Risky

Mar 26
CK Life Sciences Int'l. (Holdings) (HKG:775) Use Of Debt Could Be Considered Risky

Here's Why CK Life Sciences Int'l. (Holdings) (HKG:775) Can Manage Its Debt Responsibly

Sep 27
Here's Why CK Life Sciences Int'l. (Holdings) (HKG:775) Can Manage Its Debt Responsibly

Does CK Life Sciences Int'l. (Holdings) (HKG:775) Have A Healthy Balance Sheet?

Sep 16
Does CK Life Sciences Int'l. (Holdings) (HKG:775) Have A Healthy Balance Sheet?

Estimating The Intrinsic Value Of CK Life Sciences Int'l., (Holdings) Inc. (HKG:775)

Aug 21
Estimating The Intrinsic Value Of CK Life Sciences Int'l., (Holdings) Inc. (HKG:775)

These 4 Measures Indicate That CK Life Sciences Int'l. (Holdings) (HKG:775) Is Using Debt Extensively

Apr 14
These 4 Measures Indicate That CK Life Sciences Int'l. (Holdings) (HKG:775) Is Using Debt Extensively

CK Life Sciences Int'l., (Holdings) Inc. (HKG:775) Delivered A Weaker ROE Than Its Industry

Mar 18
CK Life Sciences Int'l., (Holdings) Inc. (HKG:775) Delivered A Weaker ROE Than Its Industry

If You Had Bought CK Life Sciences Int'l. (Holdings) (HKG:775) Shares Five Years Ago You'd Have Earned 45% Returns

Feb 01
If You Had Bought CK Life Sciences Int'l. (Holdings) (HKG:775) Shares Five Years Ago You'd Have Earned 45% Returns

What Kind Of Shareholders Hold The Majority In CK Life Sciences Int'l., (Holdings) Inc.'s (HKG:775) Shares?

Jan 04
What Kind Of Shareholders Hold The Majority In CK Life Sciences Int'l., (Holdings) Inc.'s (HKG:775) Shares?

CK Life Sciences Int'l. (Holdings) (HKG:775) Has A Somewhat Strained Balance Sheet

Dec 09
CK Life Sciences Int'l. (Holdings) (HKG:775) Has A Somewhat Strained Balance Sheet

We Wouldn't Rely On CK Life Sciences Int'l. (Holdings)'s (HKG:775) Statutory Earnings As A Guide

Nov 18
We Wouldn't Rely On CK Life Sciences Int'l. (Holdings)'s (HKG:775) Statutory Earnings As A Guide

CEO 보상 분석

Alan Abel Yu 의 보수는 CK Life Sciences Int'l. (Holdings) 의 수익과 비교하여 어떻게 변경되었나요?
날짜총 보상급여회사 수익
Dec 31 2023HK$15mHK$11m

HK$17m

Sep 30 2023n/an/a

HK$61m

Jun 30 2023n/an/a

HK$104m

Mar 31 2023n/an/a

HK$118m

Dec 31 2022HK$14mHK$11m

HK$132m

Sep 30 2022n/an/a

HK$130m

Jun 30 2022n/an/a

HK$128m

Mar 31 2022n/an/a

HK$145m

Dec 31 2021HK$14mHK$10m

HK$163m

Sep 30 2021n/an/a

HK$150m

Jun 30 2021n/an/a

HK$138m

Mar 31 2021n/an/a

HK$132m

Dec 31 2020HK$14mHK$11m

HK$125m

Sep 30 2020n/an/a

HK$112m

Jun 30 2020n/an/a

HK$98m

Mar 31 2020n/an/a

HK$140m

Dec 31 2019HK$14mHK$10m

HK$182m

Sep 30 2019n/an/a

HK$223m

Jun 30 2019n/an/a

HK$263m

Mar 31 2019n/an/a

HK$263m

Dec 31 2018HK$13mHK$10m

HK$263m

Sep 30 2018n/an/a

HK$261m

Jun 30 2018n/an/a

HK$259m

Mar 31 2018n/an/a

HK$259m

Dec 31 2017HK$12mHK$9m

HK$258m

보상 대 시장: Alan Abel 의 총 보상 ($USD 1.89M )은 Hong Kong 시장( $USD 358.97K ).

보상과 수익: Alan Abel 의 보상은 지난 한 해 동안 회사 성과와 일치했습니다.

CEO

Alan Abel Yu (68 yo)

3.8yrs

테뉴어

HK$14,788,000

보상

Mr. Ying Choi Yu, also known as Alan Abel, has been the Chief Executive Officer at CK Life Sciences Int'l., (Holdings) Inc. since September 1, 2020 and serves as its Vice President and Executive Director....

리더십 팀

이름위치테뉴어보상소유권
Tzar Kuoi Li
Executive Chairman 22.3yrsHK$125.00k0.023%
HK$ 731.2k
Ying Choi Yu
CEO, VP & Executive Director3.8yrsHK$14.79m0.023%
HK$ 731.2k
Hing Lam Kam
President & Executive Director22.1yrsHK$2.58m0.065%
HK$ 2.0m
Edmond Tak Chuen IP
Senior VPno dataHK$1.60m0.023%
HK$ 731.2k
Kean Meng Toh
VP, Chief Scientific Officer & Executive Director5.7yrsHK$6.13m데이터 없음
Wun Lam Wong
Chief Financial Officerno data데이터 없음데이터 없음
Pak To Wu
Chief Operating Officer of Global Operationsno data데이터 없음데이터 없음
Yau Wong
Senior Manager of Human Resources & Administrationno data데이터 없음데이터 없음
Ching Sze Chiu
General Counselno data데이터 없음데이터 없음
Sze Ho
Vice President of Corporate Developmentno data데이터 없음데이터 없음
Wai Che Tong Barnes
Chief Corporate Affairs Officerno data데이터 없음데이터 없음
Eirene Yeung
Company Secretary22.5yrs데이터 없음데이터 없음

13.9yrs

평균 재임 기간

61yo

평균 연령

경험이 풍부한 관리: 775 의 관리팀은 노련하고 경험 (평균 재직 기간 13.8 년)입니다.

이사회 구성원

이름위치테뉴어보상소유권
Tzar Kuoi Li
Executive Chairman 22.3yrsHK$125.00k0.023%
HK$ 731.2k
Ying Choi Yu
CEO, VP & Executive Directorno dataHK$14.79m0.023%
HK$ 731.2k
Hing Lam Kam
President & Executive Directorno dataHK$2.58m0.065%
HK$ 2.0m
Edmond Tak Chuen IP
Senior VPno dataHK$1.60m0.023%
HK$ 731.2k
Kean Meng Toh
VP, Chief Scientific Officer & Executive Director5.7yrsHK$6.13m데이터 없음
Eva Kwok
Independent Non-Executive Director22.1yrsHK$100.00k0.0021%
HK$ 65.0k
Keith Frankel
Co-Chairman of Vitaquest International LLCno data데이터 없음데이터 없음
Peter Peace Tulloch
Non-Executive Director22.3yrsHK$75.00k0.011%
HK$ 341.1k
Kai Cheong Kwan
Independent Non-executive Director9.3yrsHK$155.00k데이터 없음
Donald Jeffrey Roberts
Independent Non-Executive Director4yrsHK$205.00k데이터 없음
Joseph Paul Tighe
Independent Non-Executive Director5.1yrsHK$205.00k데이터 없음

9.3yrs

평균 재임 기간

72yo

평균 연령

경험이 풍부한 이사회: 775 의 이사회는 경험(평균 재직 기간 9.3 년)으로 간주됩니다.